Tina Gupta

Tina Gupta

Auto-generated profile, based on publicly available information

Tina Gupta

Department of Psychology, University of Oregon, United States of America

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Schizophrenia Research
Verified
Journal Article
Closed access
TGTina Gupta
Tina Gupta
SHSusan J. Hespos
Susan J. Hespos
WHWilliam S. Horton
William S. Horton
VMVijay A. Mittal
Vijay A. Mittal

30 December 2017 in Schizophrenia Bulletin
Verified
Journal Article
Closed access
PDF file
TGTina Gupta
Tina Gupta
DDDerek J Dean
Derek J Dean
NKNicholas J Kelley
Nicholas J Kelley
JBJessica A Bernard
Jessica A Bernard
IRIvanka Ristanovic
Ivanka Ristanovic
VMVijay A Mittal
Vijay A Mittal
The present double-blind crossover study examines the effects of cerebellar transcranial direct current stimulation (tDCS) in controls and in an analogue population to psychosis: individuals reporting elevated symptoms of nonclinical psychosis (NCP). A total of 18 controls and 24 NCP individuals were randomized into conditions consisting of 25 minutes of anodal (active) or sham cerebellar tDCS. Following this, both groups completed a pursuit rotor task designed to measure procedural learning performance. Participants then returned 1-week later and received the corresponding condition (either active or sham) and repeated the pursuit rotor task. Results indicate that in the sham condition, control participants showed significantly greater rates of motor learning when compared with the NCP group. In the active condition, the NCP group exhibited significant improvements in the rate of motor learning and performed at a level that was comparable to controls; these data support the link between cerebellar dysfunction and motor learning. Taken together, tDCS may be a promising treatment mechanism for patient populations and a useful experimental approach in elucidating our understanding of psychosis.

25 June 2020 in Emotion
Verified
Journal Article
Closed access
TGTina Gupta
Tina Gupta
CHClaudia M. Haase
Claudia M. Haase
GSGregory P. Strauss
Gregory P. Strauss
ACAlex S. Cohen
Alex S. Cohen
JRJordyn R. Ricard
Jordyn R. Ricard
VMVijay A. Mittal
Vijay A. Mittal
Alterations in facial expressions of emotion are a hallmark of psychopathology and may be present before the onset of mental illness. Technological advances have spurred interest in examining alterations based on “thin slices” of behavior using automated approaches. However, questions remain. First, can alterations be detected in ultrathin slices of behavior? Second, how do automated approaches converge with human coding techniques? The present study examined ultrathin (i.e., 1-min) slices of video-recorded clinical interviews of 42 individuals at clinical high risk (CHR) for psychosis and 42 matched controls. Facial expressions of emotion (e.g., joy, anger) were examined using two automated facial analysis programs and coded by trained human raters (using the Expressive Emotional Behavior Coding System). Results showed that ultrathin (i.e., 1-min) slices of behavior were sufficient to reveal alterations in facial expressions of emotion, specifically blunted joy expressions in individuals at CHR (with supplementary analyses probing links with attenuated positive symptoms and functioning). Furthermore, both automated analysis programs converged in the ability to detect blunted joy expressions and were consistent with human coding at the level of both second-by-second and aggregate data. Finally, there were areas of divergence across approaches for other emotional expressions beyond joy. These data suggest that ultrathin slices of behavior can yield clues about emotional dysfunction. Further, automated approaches (which do not require lengthy training and coder time but do lend well to mobile assessment and computational modeling) show promise, but careful evaluation of convergence with human coding is needed.

1 May 2019 in Psychiatry Research
Verified
Journal Article
Closed access
TVTeresa Vargas
Teresa Vargas
JMJacqueline Maloney
Jacqueline Maloney
TGTina Gupta
Tina Gupta
KDKatherine S.F. Damme
Katherine S.F. Damme
NKNicholas J. Kelley
Nicholas J. Kelley
VMVijay A. Mittal
Vijay A. Mittal

21 September 2020 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
TGTina Gupta
Tina Gupta
HCHenry R Cowan
Henry R Cowan
GSGregory P Strauss
Gregory P Strauss
EWElaine F Walker
Elaine F Walker
VMVijay A Mittal
Vijay A Mittal
Negative symptoms are characteristic of schizophrenia and closely linked to numerous outcomes. A body of work has sought to identify homogenous negative symptom subgroups—a strategy that can promote mechanistic understanding and precision medicine. However, our knowledge of negative symptom subgroups among individuals at clinical high-risk (CHR) for psychosis is limited. Here, we investigated distinct negative symptom profiles in a large CHR sample (N = 244) using a cluster analysis approach. Subgroups were compared on external validators that are (1) commonly observed in the schizophrenia literature and/or (2) may be particularly relevant for CHR individuals, informing early prevention and prediction. We observed 4 distinct negative symptom subgroups, including individuals with (1) lower symptom severity, (2) deficits in emotion, (3) impairments in volition, and (4) global elevations. Analyses of external validators suggested a pattern in which individuals with global impairments and volitional deficits exhibited more clinical pathology. Furthermore, the Volition group endorsed more disorganized, anxious, and depressive symptoms and impairments in functioning compared to the Emotion group. These data suggest there are unique negative symptom profiles in CHR individuals, converging with studies in schizophrenia indicating motivational deficits may be central to this symptom dimension. Furthermore, observed differences in CHR relevant external validators may help to inform early identification and treatment efforts.

28 May 2018 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
PDF file
TGTina Gupta
Tina Gupta
NKNicholas J. Kelley
Nicholas J. Kelley
APAndrea Pelletier-Baldelli
Andrea Pelletier-Baldelli
VMVijay A. Mittal
Vijay A. Mittal
Schizophrenia is a chronic, debilitating condition that affects approximately 1% of the population. Individuals diagnosed with schizophrenia typically exhibit positive (e.g., hallucinations) and negative symptoms (e.g., anhedonia) and impairments in cognitive function. Given the limitations of antipsychotic medication and psychotherapy in fully treating psychosis symptomatology, there has been increasing interest in other interventions such as transcranial direct current stimulation (tDCS). tDCS is a non-invasive neuromodulation technique, that is safe, cost-effective, and widely accessible. Here, we discuss treatment studies that seek to improve symptoms and cognitive performance in schizophrenia using tDCS. Currently within the literature, there is support for reductions in positive symptoms such as hallucinations after receiving tDCS. Further, studies indicate that tDCS can improve cognitive functioning, which is an area of investigation that is sorely needed, as it is unclear which types of interventions may be useful in ameliorating cognitive deficits among this group. Taken together, the evidence suggests that tDCS holds promise in improving symptoms and cognition. To that end, tDCS has critical clinical implications for this population.